Transcriptional regulation of BEST1 in retina pigment epithelium.
Transcriptional regulation of BEST1 in retina pigment epithelium.
批准号:
10200053
负责人:
Yin Shen
金额:
$39.91万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-30 至 2022-12-31
关键词:
AffectAge of OnsetAllelesBiological ProcessBiological TestingBlindnessCISH geneCRISPR/Cas technologyCell LineChIP-seqChromatinChromatin Conformation Capture and SequencingCodeDiseaseDisease ProgressionDistalDominant-Negative MutationElementsEnhancersEquilibriumEye diseasesFamily memberFrequenciesGene ExpressionGene Expression RegulationGene MutationGene ProteinsGene SilencingGenesGeneticGenetic Enhancer ElementGenetic TranscriptionGenetic VariationGenomeGenomic approachGoalsHomoHumanIndividualIon ChannelKnowledgeLinkLipofuscinLocationMapsMediatingMethodsModelingMolecularMutationNonhomologous DNA End JoiningNucleic Acid Regulatory SequencesOphthalmic examination and evaluationOutcome StudyPatientsPhasePhenotypePigmentsPoint MutationRegulatory ElementReporterResearchResolutionRetinaSiteStructure of retinal pigment epitheliumSynapsesSystemTestingTranscription Initiation SiteTranscriptional RegulationTransplantationUntranslated RNAValidationVisionVitelliform macular dystrophybasecausal variantcell typeclinical phenotypedensitydesigneffectiveness testingepigenomicsfunctional genomicsgenome editinggenomic locushuman embryonic stem cellin vivoinduced pluripotent stem cellinsightmutantnew therapeutic targetnovelpromotertherapeutic genome editingtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
The overarching goal of this study is to understand how BEST1 expression is modulated by cis-regulatory
elements in the retinal pigment epithelium (RPE). The variability of retinal phenotypes and age of onset of
visual loss, even in individuals who carry the same causative mutation, is one of the biggest mysteries for
BEST1 related diseases. Genetic variations in non-coding regulatory elements can serve as an attractive
model to provide the molecular basis for the observed various onsets of BEST1 vitelliform macular dystrophy
(BVMD) in patients. Therefore understanding the transcriptional control mediated by cis-regulatory elements in
the RPE will give us insight into novel target regions for therapeutic editing of the enhancer elements identified
by this study. We are utilizing human induced pluripotent stem cells (iPSCs)-derived RPEs as a model to
understand cell type-specific transcriptional controls of BEST1. We are also utilizing integrative, unbiased, and
high throughput epigenomic and genetic tools to achieve the following aims: (1) We will use a high resolution
4C-seq analysis to identify potential regulatory elements that interact with the BEST1 promoter in human
primary RPE. (2) In Aim 2, we will generate BEST1 dual allele reporter lines and use these lines to interrogate
cis-regulatory elements of BEST1 in their native chromatin contexts utilizing high throughput CRIPSR/Cas9
mediated genome editing approach. (3) Finally, we will test the utilities of allelic specific enhancer deletion to
modulate allelic expression of BEST1. We expect these analyses will significantly advance our knowledge of
the precise control of BEST1 transcription in RPEs.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Dissecting functional roles of MeCP2 condensates in neurons with chemogenetic tools
-
批准号:10669793
-
项目类别:
-
资助金额:$20.19万
-
财政年份:2022
-
负责人:Yin Shen
-
依托单位:
Dissecting functional roles of MeCP2 condensates in neurons with chemogenetic tools
-
批准号:10487879
-
项目类别:
-
资助金额:$24.23万
-
财政年份:2022
-
负责人:Yin Shen
-
依托单位:
海外基金